DDrare: Database of Drug Development for Rare Diseases

Searched query = "Ehlers-Danlos syndrome", "EDS", "cEDS", "hEDS", "clEDS", "vEDS", "kEDS", "aEDS", "dEDS", "DDEDS"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = 0.9% Sodium Chloride Injection; Bupivacaine; Bupivacaine Injection 0.5%; Celiprolol; Chloride; Control; Device: Kera-X; IRBESARTAN; Irbesartan; Lidocaine; Lidocaine Injection 2%; Mecasermin; Mind-body therapy; Riboflavin; Saline; Sodium chloride

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00001966 (ClinicalTrials.gov)	January 2000	18/1/2000	Mind-Body Therapy for Pain in Ehlers-Danlos Syndrome	A Pilot Study of Mind-Body Therapy for Chronic Pain in Ehlers-Danlos Syndrome	Ehlers-Danlos Syndrome;Pain	Drug: Mind-body therapy	National Human Genome Research Institute (NHGRI)	NULL	Completed	N/A	N/A	Both	40	Phase 2	United States

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00001966
(ClinicalTrials.gov)

January 2000

18/1/2000

Mind-Body Therapy for Pain in Ehlers-Danlos Syndrome

A Pilot Study of Mind-Body Therapy for Chronic Pain in Ehlers-Danlos Syndrome

Ehlers-Danlos Syndrome;Pain

Drug: Mind-body therapy

National Human Genome Research Institute (NHGRI)

NULL

Completed

N/A

Both

Phase 2

United States